Issues in the management of nasopharyngeal carcinoma

Critical Reviews in Oncology/Hematology

Volumn 31, Issue 1, 1999, Pages 55-69

  Liu, Taifu ^a  

^a Shanghai Cancer Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER INVASION; CANCER STAGING; DIAGNOSTIC APPROACH ROUTE; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION INJURY; REVIEW; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; DISEASE MANAGEMENT; HUMANS; NASOPHARYNGEAL NEOPLASMS;

EID: 0033014307     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(99)00003-7     Document Type: Review

References (110)

1. Clifford P. On the epidemiology of nasopharyngeal carcinoma. Int. J. Cancer. 5:1970;287-309.
2. National Cancer Control Office, Nanjing Institute of Geography. Atlas of cancer in the People's Republic of China, Shanghai: China Map Press, 1980.
3. Tsao S.Y. Staging. Chong V.F.H, Tsao S.Y. Nasopharyngeal Carcinoma. 1997;Armour Publishing, Singapore.
4. Altun M., Fandi A., Dupus O. et al. Undifferentiated carcinoma (UNCT): current diagnostic and therapeutic aspects. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;859-877.
5. Geara F.B., Sanguineti G., Tucker S.L. et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother. Oncol. 43:1997;53-61.
6. Teo P., Yu P., Lee W.Y. et al. Significant prognosticators after primary radiotherapy in 903 non-disseminated nasopharyngeal carcinoma evaluated by computer tomography. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;291-304.
7. Chua D.T.T., Sham J.S.T., Kwong D.L.W. et al. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. Cancer. 76:1996;202-210.
8. Liu T.F. Trends in the clinical management of nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;469-471.
9. Xiao G.L., Cai W.M., Hu Y.H. et al. Evaluation and revision comments of the TNM staging classification on nasopharyngeal carcinoma (NPC) proposed by UICC. Chin. J. Radiat. Oncol. 3:1994;6-9.
10. Liao YP, Xiao F, Xi XP, et al. Clinical staging analysis of 2000 cases. Chin J Radiat Oncol 1993; 2: 190-191.
11. Zhai I.M., Tian S.Y., Han J.Q. et al. The influence of incisional biopsy of nasopharyngeal carcinoma on prognosis. Chin. J. Radiat. Oncol. 5:1996;228-229.
12. Wei W.I., Sham J.S., Zong Y.S. et al. The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma. Cancer. 67:1991;3127-3130.
13. Ahmad A., Stefani S. Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients. J. Surg. Oncol. 33:1986;194-197.
14. Fu KK. Re-irradiation of locally recurrent nasopharyngeal carcinoma. Proc UICC Workshop Nasopharyngeal Cancer, Feb 11-14, 1998, Singapore.
15. Sasco A.J. Screening of undifferentiated carcinoma of the nasopharynx. Bull. Cancer (Paris). 83:1996;344-351.
16. De Vathaire F., Sancho-Garnier H., De-The G. Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC). A multi-center follow-up study. Int. J. Cancer. 42:1988;176-181.
17. Zong Y.S., Sham J.S., Ng M.H. et al. Immunoglobulin A against viral capsule antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 69:1992;3-7.
18. Kuo W.R., Tsai S.M., Jong S.B. et al. Significance of tumor markers in nasopharyngeal carcinoma. J. Otolaryngol. 25:1996;32-36.
19. Rousselet G., Bachouchi M., Busson P. et al. Clinical implication of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma. J. Clin. Oncol. 11:1993;2143-2149.
20. Cheng C.Q., Zheng J.J. Discussion on the planning of radiotherapy fields for NPC cases with paranasopharyngeal space invasion. Cancer (Chinese). 6:1988;446.
21. Wei B.Q. The value of coronal CT section in nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 2:1993;60.
22. Tan E.L., Chua S.I., Kwok R. Use of magnetic resonance imaging in the evaluation of nasopharyngeal cancer. Am. Acad. Med. Singapore. 22:1993;722-723.
23. Chong V.F.H., Fan Y.F. Skull base erosion in nasopharyngeal carcinoma. Detection by CT and MRI. Clin. Radiol. 51:1996;625-631.
24. Ming H.Q., Hong M.H., Ma J. et al. A new staging system for nasopharyngeal carcinoma in China. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;1037-1042.
25. Lee AWM, Poo W, Law CK et al. Staging and prognostic factors in NPC-the HK experience. Proc UICC Workshop Nasopharyngeal Cancer. Issues and Challenges, Feb. 11-14, 1998, Singapore.
26. Chua D.T.T., Sham J.S.T., Kwong D.L.W. et al. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. Cancer. 78:1996;202-210.
27. Huan Sl, Jiang GL, Yan QY. Clinical significance of paranasopharyngeal space extension in nasopharyngeal carcinoma. Chin J Radiat Oncol 1993; 2: 218-220.
28. Chua D.T., Sham J.S., Kwong D.L. et al. Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma: a computed tomography-based study. Cancer. 79:1977;869-877.
29. O'Sullivan B. The new TNM staging classification of carcinoma of the nasopharynx. Proc UICC Workshop on Nasopharyngeal Cancer. Issues and Challenges, Feb. 11-14, 1998, Singapore.
30. Chua D.T.T., Sham J.S.T., Kwong D.L.W. et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;711-719.
31. Teo P. Summation against chemotherapy. Proc UICC Workshop on Nasopharyngeal Cancer. Issues and Challenges, Feb. 11-14, 1998, Singapore.
32. :Yan JH, Xu GZ, Li SY, et al. Combined radiotherapy and medical agents for naso-pharyngeal carcinoma (NPC) with high risk of distant metastasis. Chin J Radiat Oncol 1994;4:158-160.
33. Hu G.Q., Hu C.Y., Chen Y. Combined radiotherapy and cisplatin for advanced nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 3:1994;244-246.
34. Perez C.A., Devineni V.R., Marcial-Vega V. et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;271-280.
35. Lee AWM, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 261-270.
36. Meeks S.L., Buatti J.M., Friedman W.A. et al. Potential clinical efficacy of intensity-modulated conformal therapy. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;483-495.
37. Eisbruch A., Marsh L.H., Martel M.K. et al. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: asessment of target coverage and noninvolved tissue sparing. Int. J. Radiat. Oncol. Biol. Phys. 41:1998;559-568.
38. Perez C.A., Purdy J.A., Harms W. et al. Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation. Radiother. Oncol. 36:1995;32-43.
39. Kuncher G.I., Fuks Z., Brenner H. et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;169-182.
40. Luo R.X., Tang Q.X., Guo K.P. et al. Comparison of treatment results of conventional and split course radiotherapy in 1446 patients with nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 3:1994;78-81.
41. Stuschke M., Thames H.D. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;259-267.
42. Withers H.R., Peters L.J., Thames H.D., Fletcher G.H. Hyperfractionation. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;1807-1809.
43. Fowler J.F. Nonstandard fractionation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;755-759.
44. Barendsen G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int. J. Radiat. Oncol. 8:1982;1981-1997.
45. Withers H.R, Thames H.D., Peters L.J. Differences in the fractionation response of acute and late responding tissues. Karcher K.H., Kogelink H.D., Rheinartz G. Progress in Radio-oncology II. 1982;287-296 New York, Raven Press.
46. Withers HR. The 4 R's of radiotherapy. In: Lett JT, Adler H, editors. Advances in radiation biology, Vol. 5, 241, Academic Press: New York, 1975.
47. Hellman S. Cell kinetics, models and cancer treatment. Some principles for the radiation oncologist. Radiology. 114:1975;219-223.
48. Thomlinson R.H., Gray L.H. The histological structure of some human lung cancers and possible implications for radiotherapy. Br. J. Cancer. 9:1955;539-549.
49. Kallman R.F. The phenomenon of re-oxygenation and its implications for fractionated radiotherapy. Radiology. 105:1972;135-142.
50. Keane TJ. Hypoxia in radiation therapy - is it relevant to nasopharyngeal cancer treatment? Proc UICC Workshop Nasopharyngeal Cancer. Issues and Challenges, Feb. 11-14, 1998, Singapore.
51. Delides G.S., Venizelos J., Revesz L. Vascularisation and curability of stage III and IV nasopharyngeal tumors. J. Can. Res. Clin. Oncol. 114:1988;321-323.
52. Miao Y.Y., He S.Q., Feng Y. et al. Relationship between inter-capillary distance monitored by 'morphometric methods (VIDS III IMAGE) analysis system and radiocurabillity of nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 2:1993;223-225.
53. Thomlinson R.H., Grat L.H. The histological structure of some human lung cancers and the possible impllications in radiotherapy. Br. J. Radiol. 9:1955;539-549.
54. Keane TJ, Chow E, Izzard M, et al. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1997;1:149-54.
55. Elkind M.M., Sutton H. Radiation response of mammalian cells grown in culture: 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiat. Res. 13:1960;556-593.
56. Thames H.D., Withers H.R., Peters L.J., Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for μ dose-survival relationships. Int. J. Radiat. Oncol. 8:1982;219-226.
57. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy - a review. Br. J. Radiol. 62:1989;679-694.
58. Hermens A.F., Barendson G.W. Changes in cell proliferation characteristics in a ratrhabdomyosarcoma before and after X-irradiation. Eur. J. Cancer. 5:1969;173-189.
59. Maciejewski B., Withers H.R., Taylor J.M., Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;831-843.
60. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta. Oncol. 27:1988;131-146.
61. Teo P., Lee W.Y., Leung S.F. et al. Early tumor response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma. Br. J. Radiol. 69:1996;241-248.
62. Nyman J., Turesson I. Does the interval between fractions matter in the range of 4-8 hours in radiotherapy? A study of acute and late human skin reaction. Radiother. Oncol. 34:1995;171-178.
63. Ang K.K., Peters L.J., Weber R.S. et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1339-1345.
64. Hu CS. Accelerated fractionation in nasopharyngeal carcinoma. Proc UICC Workshop on Nasopharyngeal Cancer. Issues and Challenges, Feb. 11-14, 1998, Singapore.
65. Lee A.W.M., Foo W., Poon Y.F. et al. Staging of nasopharyngeal carcinoma: evaluation of N-staging by Ho and UICC/AJCC System. Clin. Oncol. 8:1996;146-154.
66. Wang C.C. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Cancer. 63:1989;2461-2467.
67. Hall EJ. The radiobiology of brachytherapy. Proc Int Congr Radiat Oncol 97, Radioth Oncol 1997; 43(2), June 5-7, Beijing, China, Abs 119.
68. Fowler J.F. The radiobiology of brachytherapy. Martinez A.A, Orton C.G., Mould R.F. Brachytherapy HDR and LDR. 1990;121-137 BPCC Hazell Books, Bucks, UK.
69. Deehan C., O'Donoghue J.A. Biological equivalence of LDR and HDR brachytherapy. Mould R.F., Battermann A.A., Martinez A.A., Speiser B.L. Brachytherapy from Radium to Optimization. 1994;19-33 Veenman Drukkers, Wageningen.
70. Swift PS, Fu KK, Phillips T, et al. Pulsed low dose rate interstitial and intracavitary therapy - the clinical experience at UCSF. In: Mould RF, Battermann AA, Martinez AA, Speiser B.L. editors. Brachytherapy from Radium to Optimization. Wageningen: Veenman Drukkers, 1994: 254-259.
71. Fu KK. Interactions of chemotherapeutic agents with radiotherapy. In: Frontiers in Radiation Therapy and Oncology 1992; 26: 16-30.
72. Chang C.P., Liu T.F., Chang Y.W. et al. Radiation therapy of nasopharyngeal carcinoma. Acta. Radiol. Oncol. 19:1980;433-438.
73. Liu T.F. Recent developments in diagnosis and treatment of nasopharyngeal carcinoma. Keio. J. Med. 40:1991;59-62.
74. Bachouchi M., Cvitkovic E., Azli N. et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J. Natl. Cancer. Inst. 82:1990;616-620.
75. Teo P.M.L., Leung W.T., Chan A.T.C. et al. A retrospective study of the use of cisplatinum-5-fluoracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC). European. J. Can. 31B:1991;373-379.
76. Dimery I., Peters L.J., Goepfert H. et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharygeal carcinoma. J. Clin. Oncol. 11:1993;1919-1928.
77. Fountzilas G., Danilidis A., Kosmidis P. et al. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases. Acta. Oncol. 30:1991;831-834.
78. Cvitkovic E, Hasbini A, Taamma A. Chemotherapy (CT) in nasopharyngeal cancer (NPC): the International Nasopharyngeal Cancer Study Group (INCSG) and Institut Gustave Roussy (IGR) experiences. Proc UICC Workshop Nasopharyngeal Cancer Feb 11-14, 1998, Singapore.
79. Chan A.T.C., Teo P.M.L., Leung T.W.T. et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol; Phys. 33:1995;569-577.
80. Tannock I., Payne D., Cummings B. et al. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long term benefit despite a high rate of tumour response to chemotherapy. J. Clin. Oncol. 5:1987;629-634.
81. Choi K.N., Rotman M., Aziz H. et al. Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors. Int. J. Radiat. Oncol. Biol. Phys. 39:1997;823-829.
82. Lin J.C., Jan J.S., Hsu C.Y. Pilot study of concurrent chemotherapy and radiotherapy for Stage IV nasopharygneal cancer. Am. J. Clin. Oncol. 20:1997;6-10.
83. Al-Sarraf M., LeBlanc M., Giri P.G.S. et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup Study 0099. J. Clin. Oncol. 4:1998;1310-1317.
84. Lin J.C., Jan J.S., Hsu C.Y. Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. Am. J. Clin. Oncol. 19:1996;624-627.
85. Rossi A., Molinari R., Boracchi P. et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J. Clin. Oncol. 6:1988;1401-1410.
86. Yan J.H., Hu Y.H., Gu X.Z. Radiation therapy of recurrent nasopharyngeal carcinoma. Report on 219 patients. Acta. Radiol. [Oncol]. 22:1983;23-28.
87. Sun Dr, Li XH. Anaysis of 220 cases of recurrent nasopharyngeal carcinoma. Chin J Radiat Oncol 1993; 2: 192-193.
88. Lee A.W.M., Foo W., Law S.C.K. et al. Re-irradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int. J. Radiat. Oncol. 38:1997;43-52.
89. Wang C.C. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;953-956.
90. Pryzant R.M., Wendt C.D., Delclos L., Peters L.J. Re-treatment of nasopharyngeal carcinoma in 53 patients. Int. J. Radiat. Oncol. 22:1992;941-947.
91. Fu KK, Hwang JM, Phillips TL. Re-irradiation of locally recurrent nasopharyngeal carcinoma. Proc UICC Workshop Nasopharyngeal Cancer Feb 11-14,1998, Singapore.
92. Choy D, Wei WI, Sham ST et al. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma. Proc UICC Workshop Nasopharyngeal Cancer Feb 11-14, 1998, Singapore.
93. Siu L.L., Czaykowski P.M., Tannock I.F. Phase I/II study of CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx. J. Clin. Oncol. 16:1998;2514-2521.
94. Gebbia V, Zerillo G, Restivo G et al. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases. Br J Cancer 1993; 68: 191-194.
95. Zhang Z., Chen X.P., Zhang T.Q., He S.Q. Re-irradiation of recurrent nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 7:1998;37-40.
96. Morton R.P., Liavaag P.G., McLean M., Freeman J.L. Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer. Head. Neck. 18:1998;352-358.
97. Wei W.I., Ho C.M., Yuen P.W. et al. Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch. Otolaryngol. Head. Neck. 121:1995;638-642.
98. Morton RP. Salvage surgery for primary recurrence of nasopharyngeal cancer: indications and overview. Proc UICC Workshop Nasopharyngeal Cancer Feb 11-14, 1998, Singapore.
99. Tsao S.Y. Nasopharyngeal carcinoma - a review of radiotherapy techniques. Ann. Acad. Med. Singapore. 22:1992;638-645.
100. Lee AW, Law SC, Ng SH et al. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. Br J Radiol 1992; 65: 918-928.
101. Hu J.Q., Guan Y.H., Zhao L.Z. et al. Delayed radiation encephalopathy after radiotherapy for nasopharyngeal cancer. A CT study of 45 cases. J. Comput. Assist. Tomogr. 15:1991;181-187.
102. Lee A.W.M., Foo W., Chappell R. et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 40:1998;35-42.
103. Wei BQ. Radiation induced cranial neuropathy (RICN) after radiotherapy for nasopharyngeal carcinoma (NPC). Cause related to radiation technique. Chin J Radiat Oncol 1994; 3: 164-168.
104. Parsons J.T., Fitzgerald C.R., Hood C.I. et al. The effects of irradiation on the eye and optic nerve. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;609.
105. Archer D.B., Amoaka W.M., Gardiner T.A. Radiation retinopathy - clinical, histological, ultrastructural and experimental correlations. Eye. 5:1991;239.
106. Hu W.H., Wu D.H., Huang X.Y. et al. The functional damage of visual pathway in radiotherapy of nasopharyngeal carcinoma. Chin. J. Radiat. Oncol. 4:1995;150-154.
107. Xu F., Lang J.Y., Wen H. et al. Dynamic follow-up of posradiation NPC by CT and MRI. Chin. J. Radiat. Oncol. 4:1995;185.
108. QY, Gong Zheng GI, Zhu HY. MRI differentation of recurrent nasopharyngeal carcinoma from postradiation fibrosis. Comput Med Imaging Graph 1991; 15: 423-429.
109. Gong Q.Y., Zhu H.Y., Zheng G.I. et al. MRI-T2 values in the differentiation of recurrence and fibrosis after radiation of nasopharyngeal carcinoma. Chin. Med. (Engl). 105:1992;135-138.
110. Fujii M., Kanzaki J. The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer. Auris Nasus Larynx (Abstr. 21. 56):1994;32-37.